Wisconsin Rx National CooperativeRx
The SCRxIPT - Weekly Newsletter For Members and Stakeholders
Rx News | December 10, 2010
How To Join Rx
About Us
The Co-op Difference
Members
Employers
Brokers and TPAs
Cost Savings
Adding Value
Press Room
Event Calendar
_________________________
 
Upcoming Events featuring
National CooperativeRx
Health Benefits Conference and Expo
January 31 to February 1, 2011
Sheraton Sand Key Resort, Clearwater Beach, FL 
Learn more ________________________
National CooperativeRx is a not-for-profit coalition founded and owned by plan sponsors to achieve higher value prescription benefits through volume purchasing, clinical solutions, actionable data and unparalleled customer service. For your sales and marketing needs, please contact us at info@wisrx.com or by phone at 866-679-9479, ext. 223.

Coalition News
National CooperativeRx Presents:
 
Designing Benefit Plans for Improved Outcomes
A Noon Hour Webinar with John Miall, Asheville Project Visionary

12:00 Noon-1:00 CST on December 14, 2010
To join the webinar, click here and enter moderator number 2396569.
Registration instructions and additional details can be found on our homepage.
 
News You Can Use

HealthDay.  Long-term use of a daily low-dose aspirin dramatically cuts the risk of dying from a wide array of cancers, a new investigation reveals. (Mozes, 12/7) Full story

HealthDay.  Even as fewer Americans have sought psychotherapy for their depression, antidepressant prescription rates have continued to climb in recent years, a new survey finds. (Mozes, 12/7) Full story

 

LA Times. Employers are offering innovative wellness programs to cut health costs. (Von Bergen, 12/7) Full story

 
Industry News

Bloomberg. Abbott Laboratories and two other drugmakers agreed to pay $421.2 million to settle claims they overcharged the U.S. for medicines, the Justice Department said. (Blum & Voreacos, 12/7) Full story

 

Personalized Medicine Coalition.  Issues a report that claims the US health care reimbursement system slows the progress of personalized medicine. (12/2010) Report

 

Medical News Today.  An FDA committee has recommended an experimental drug, Concave, be approved for the treatment of obesity. (Nordqvist, 12/8) Full story

 

New York Times.  In a closely watched case, a federal jury on Wednesday awarded a Minnesota resident a total of $1.82 million in damages, finding that Johnson & Johnson had failed to adequately warn patients that its antibiotic Levaquin may cause tendon damage. (12/8) Full story


Health Policy Matters

Chicago Tribune. The U.S. Postal Service may be in dire need of drastic reform to ensure its viability, but the most talked-about proposal - eliminating Saturday mail delivery - has the potential to harm millions of Americans who depend on delivery of needed medicines. (Czarnecki, 12/8) Full story

 

Wall Street Journal.  Republicans should talk less about "death panels" and more about cutting the overuse of expensive medical procedures, said a powerful GOP lawmaker who has the health industry in his sights. (Mundy, 12/9) Full story

 

Wall Street Journal. In another attempt at jump-starting drug development, the National Institutes of Health's Scientific Management Review board recommended the NIH create a center to help turn promising scientific discoveries into drugs. (Dockser Marcus, 12/8) Full story